Lauren Banaszak, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Leukemia
- Myelodysplastic syndrome (MDS)
- Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
My Specialties
- Genetic testing and counseling
Get to Know Me
I am a medical oncologist and hematologist who specializes in the care of people with acute myeloid leukemia, myelodysplastic syndrome, and other leukemias. I also have a special interest in caring for people with an inherited risk for cancer. I see patients at Memorial Hospital and the Memorial Sloan Kettering Clinical Genetics Service.
I work closely with a team of physicians, advanced practice providers, and nurses who are part of Memorial Sloan Kettering Cancer Center to provide the best treatment for patients with leukemia and other blood cancers. It is my privilege to educate patients and their families on their diagnosis and treatment options and to work together to create a personalized care plan based on their individual goals.
In addition, I have a separate genetics clinic where I provide genetic counseling and testing for people who may have an inherited predisposition to cancer. I also help patients diagnosed with cancer integrate this genetic information into their treatment plan. Though I see patients with inherited risk for all cancer types, I specialize in hereditary blood cancers. My goal is to partner with patients and their families to discover new ways to detect and treat these disorders.
I’m a leukemia specialist, which is a doctor with special training in diagnosing and treating leukemia (loo-KEE-mee-uh). This cancer starts in tissue that forms blood, such as bone marrow.
- Clinical Instructor
- Lead, Inherited Hematologic Cancer
Conditions I Treat
- Leukemia
- Myelodysplastic syndrome (MDS)
- Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
- Hereditary cancers
My Specialties
- Genetic testing and counseling
Education
- MD, Cleveland Clinic Lerner College of Medicine
Residencies
- Internal Medicine, University of Wisconsin-Madison
Fellowships
- Hematology/Medical Oncology, University of Wisconsin-Madison
Board Certifications
- Hematology
- Medical Oncology
- Internal Medicine
Awards and Honors
- Fellow Outstanding Research Award, University of Wisconsin-Madison Department of Medicine (2024)
- Outstanding Fellow Award, University of Wisconsin-Madison Department of Medicine (2024)
- Chief Resident, University of Wisconsin-Madison (2020-2021)
- Abstract Achievement Award (2016, 2019)
- Medical Research Scholars Program Fellow, National Institutes of Health (2015-2016)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Banaszak LG, Cabral PL, Smith-Simmer K, Hassan A, Brunner M, Fallon M, Shoger K, Lovrien L, Golner D, Zurbriggen L, Mattison R, Gahvari Z, Hall A, Nadiminti K, Reinig E, Churpek JE. Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia. JCO Precis Oncol. 2024 Jun;8:e2300518. doi: 10.1200/PO.23.00518. PMID: 38848520; PMCID: PMC11234342.
Banaszak LG, Smith-Simmer K, Shoger K, Lovrien L, Malik A, Sandbo N, Sultan S, Guzy R, Lowery EM, Churpek JE. Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease. Respir Med. 2023 Dec;220:107464. doi: 10.1016/j.rmed.2023.107464. Epub 2023 Nov 10. PMID: 37951311.
Banaszak LG, Reinig E, Lasarev MR, Mattison RJ. Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromes. Leuk Lymphoma. 2022 Mar;63(3):684-693. doi: 10.1080/10428194.2021.1999435. Epub 2021 Dec 6. PMID: 34865601.
Banaszak LG, Giudice V, Zhao X, Wu Z, Gao S, Hosokawa K, Keyvanfar K, Townsley DM, Gutierrez-Rodrigues F, Fernandez Ibanez MDP, Kajigaya S, Young NS. Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing. Blood Cells Mol Dis. 2018 Mar;69:10-22. doi: 10.1016/j.bcmd.2017.12.002. Epub 2018 Jan 4. PMID: 29324392; PMCID: PMC6728079.
Bade R, Banaszak LG, Osman F, Cabral P, Hassan A, Stepanovic A, Reinig E, Mattison RJ. Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemia. Leuk Res. 2023 Aug;131:107326. doi: 10.1016/j.leukres.2023.107326. Epub 2023 May 24. PMID: 37263074.
Visit PubMed for a full listing of Dr. Banaszak’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Lauren Banaszak discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.